SMARCAL1 Favors Tumor Immune Evasion Through Dual Mechanisms

Overview of attention for article published in Cancer Discovery, January 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 35,270 followers.

SMARCAL1 drives tumor immune escape by suppressing innate immune signaling and inducing PD-L1 expression. #MedEd #MedX #immunotherapy

RT @CD_AACR: Read Cancer Discovery's #ResearchWatch: SMARCAL1 Favors Tumor Immune Evasion Through Dual Mechanisms, summarizing the work of…

RT @CD_AACR: Read Cancer Discovery's #ResearchWatch: SMARCAL1 Favors Tumor Immune Evasion Through Dual Mechanisms, summarizing the work of…

RT @CD_AACR: Read Cancer Discovery's #ResearchWatch: SMARCAL1 Favors Tumor Immune Evasion Through Dual Mechanisms, summarizing the work of…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.